Surgical treatment for pelvic giant cell tumor: a multi-center study
Open Access
- 5 April 2016
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 1-9
Abstract
The purpose of this study was to discuss the clinical results which related to the location of giant cell tumors (GCTs) in the pelvis so as to determine the ideal surgical treatment protocol. We report 29 cases who accepted surgical treatment from five clinical centers during the last 12 years. All patients were divided into three groups according to tumor locations, and they were also classified into two groups in light of surgical treatments. The parameters for outcome evaluation consisting of general condition, surgical complications, local disease control, and Musculoskeletal Tumor Society (MSTS) 93 functional score had been analyzed, respectively. Surgical treatment in the acetabular area usually resulted in postoperative complications and poor function. One patient who accepted intralesional surgery and two who accepted wide resection had local recurrence. The mean functional score was 25.4 for the 8 patients who received intralesional surgery and 21.9 for the 21 patients who received wide resection. Surgical complications occurred in 1 patient who underwent intralesional surgery and the other 6 patients who underwent wide resection. We conclude that surgical treatment of pelvic GCTs in the acetabular area is difficult to select as it is always accompanied by complications and poor function. Compared to wide resection, intralesional surgery combined with a meticulous preoperative planning may lower the recurrence rate and obtain favorable postoperative functional results.Keywords
This publication has 31 references indexed in Scilit:
- Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studyThe Lancet Oncology, 2013
- Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonatesOncology Letters, 2012
- Intralesional Excision versus Wide Resection for Giant Cell Tumor Involving the Acetabulum: Which is Better?Clinical Orthopaedics and Related Research, 2012
- Interferon Alfa-2b for Recurrent and Metastatic Giant Cell Tumor of the SpineSpine, 2010
- Giant cell tumor of the sacrum treated with selective arterial embolizationInternational Journal of Clinical Oncology, 2010
- Treatment and outcome of giant cell tumors of the pelvisActa Orthopaedica, 2009
- Risk Factors for Blood Loss During Sacral Tumor ResectionClinical Orthopaedics and Related Research, 2008
- Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapyEuropean Journal of Surgical Oncology, 2001
- Surgical Management of Innominate Giant Cell TumorClinical Orthopaedics and Related Research, 1996
- Pelvic OsteosarcomaClinical Orthopaedics and Related Research, 1991